Affiliation:
1. Moscow Research and Practice Center for Medical Rehabilitation, Restorative and Sports Medicine; Pirogov Russian National Research Medical University
2. Moscow Research and Practice Center for Medical Rehabilitation, Restorative and Sports Medicine
Abstract
Introduction. The relevance of neuroprotective therapy in patients with cerebral stroke (CS) is due to its high prevalence, as well as the need for the maximum possible restoration of damaged structures and functions of the central nervous system (CNS).Аim. Тo evaluate the clinical efficacy and nicotinoyl gamma-aminobutyric acid tolerance in the complex rehabilitation of patients in the late recovery and chronic periods of ischemic stroke (IS) in outpatient stage.Materials and methods. 110 patients in the late recovery period (LRP) and the residual period of IS, 57 women and 43 men, average age 58.0 ± 9.74 years, were observed. The duration of the stroke was on average 214 ± 28 days in PVP-patients and 428 ± 47 days for the residual period. All patients included in the study received a standard medical rehabilitation program. Two main groups included 30 patients in LRP and the residual period of IS, who treated with nicotinoyl gammaaminobutyric. Two control groups included 30 patients in LRP and 20 patients in the residual period of IS, who recievedonly the standard medical rehabilitation program.Results. The complex of rehabilitation with the inclusion of nicotinoyl gamma-aminobutyric acid (picamilon) significantly improved the indicators of neurodynamic (p < 0.05) and regulatory functions (p < 0.05) in the main subgroups on the MoCA scale, emotional status (p > 0.05 on the Beck scale), general well-being, activity, mood (WAM scale) and basic functional activity (the average Bartel index at the end of the study was 82.6 ± 3.5 in the main groups, p < 0.05). The clinical effect was observed after a month of the therapy and persisted until the end of the study.Conclusion. The inclusion of neuroprotective therapy in the complex rehabilitation leads to earlier neuropsychological and social adaptation of the patient, regression of fatigue, which is probably associated with an increase in neuroplastic and regulatory brain processes.
Reference37 articles.
1. Kostenko EV, Eneeva MA. Chronic cerebrovascular diseases: pathogenetic heterogeneity and therapeutic strategies. Meditsinskiy Sovet. 2018;(18):50–55. (In Russ.) https://doi.org/10.21518/2079-701X-2018-18-50-55.
2. Gromova DO, Zakharov VV. Issues of patient management in the recovery period of ischemic stroke. Effective Pharmacotherapy. 2020;16(4):8–16. (In Russ.) https://doi.org/10.33978/2307-3586-2020-16-4-8-16.
3. Кадыков АС, Черникова ЛА, Шахпаронова НВ. Реабилитация неврологических больных. М.: МЕДпресс-информ; 2008. 560 с.
4. Скоромец АА (ред.). Мультидисциплинарный подход в ведении и ранней реабилитации неврологических больных. СПб.; 2003. 20 с.
5. Farrakhov AZ, Khabirov FA, Ibragimov MF, Khaybullin TI, Granatov EV. Complex rehabilitation of patients with ischemic stroke, at the stages hospital-rehabilitation center – polyclinic. Neurology Bulletin. 2012;44(4):3–8. (In Russ.) Available at: http://elib.fesmu.ru/eLib/Article.aspx?id=273174&ysclid=lofms7yoqv679029804.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献